lapachol has been researched along with ruthenium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balsano, E; Berger, W; Göschl, S; Hartinger, CG; Jakupec, MA; Jungwirth, U; Kandioller, W; Keppler, BK; Meier, SM; Roller, A | 1 |
| Barbosa, MI; Barbosa-Filho, JM; Batista, AA; Corrêa, RS; de Oliveira, KM; Ellena, J; Macedo, TS; Nascimento, OR; Nonato, FR; Rocha, VP; Rodrigues, C; Soares, MB | 1 |
| Batista, AA; Cominetti, MR; Correa, RS; Demidoff, FC; Honorato, J; Netto, CD; Oliveira, KM; Schultz, MS | 1 |
| Batista, AA; Cerqueira, IH; Costa, AR; de Araujo-Neto, JH; De Grandis, RA; Demidoff, FC; Guedes, APM; Marques, WG; Moraes, CAF; Netto, CD; Pavan, FR; Resende, FA; Sampaio, NZ | 1 |
4 other study(ies) available for lapachol and ruthenium
| Article | Year |
|---|---|
Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.
Topics: Amino Acids; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coordination Complexes; Guanine; Humans; Naphthoquinones; Osmium; Reactive Oxygen Species; Rhodium; Ruthenium | 2013 |
Antiparasitic activities of novel ruthenium/lapachol complexes.
Topics: Animals; Antimalarials; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Leishmania; Mice; Models, Molecular; Molecular Conformation; Naphthoquinones; Plasmodium falciparum; Ruthenium; Trypanocidal Agents | 2014 |
Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Humans; MCF-7 Cells; Naphthoquinones; Neoplasms; Phosphines; Ruthenium | 2021 |
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Male; Phenanthrolines; Reactive Oxygen Species; Ruthenium | 2022 |